Vaccine Information Statements |
|
|
|
|
|
Up-to-date translations |
|
|
|
| You
are encouraged to distribute the current English version at the same time as the translation. |
|
|
|
|
|
| |
Out-of-date translations |
|
|
|
| The translations for
some VISs on our website are from previously published English-language
versions that have since been updated. Unfortunately, IAC is not always
able to obtain translations as updates are issued. Please ensure that your
patients receive information consistent with the current of
the following VISs. |
|
|
|
AMHARIC TRANSLATION OF THE JANUARY 15, 2003 MMR VIS |
|
|
|
|
|
|
| This
edition does not differ significantly from the
previous edition, particularly with regard to
contraindications and adverse events. CDC encourages
use of a new VIS upon publication; however, existing
stocks of the previous edition may be used up. |
|
| This translation does not contain the following
CDC updates: |
|
| • |
|
Information was added about MMRV vaccine, tied to the March 14 MMWR, regarding increased risk of certain adverse events, including febrile seizures, with MMRV when compared with MMR and varicella vaccines given separately. Aside from two boxes containing information about MMRV, both VISs are identical to the previous editions. |
|
|
|
| • |
|
The new VISs should be used when MMRV is given; but the existing stocks of the individual MMR and varicella VISs may be used when the vaccines are given separately. |
|
|
|
| AMHARIC TRANSLATION OF THE JANUARY 1, 2000 POLIO - IPV VIS |
|
|
|
|
|
|
| This translation does not contain the following
CDC update: |
|
| • |
|
This edition does not differ significantly from the previous edition, particularly with regard to contraindications and
adverse events. CDC encourages use of a new VIS upon publication; however, existing stocks of the previous edition may be
used up. |
|
A-Z
